Literature DB >> 25336432

A practical guide to value of information analysis.

Edward C F Wilson1.   

Abstract

Value of information analysis is a quantitative method to estimate the return on investment in proposed research projects. It can be used in a number of ways. Funders of research may find it useful to rank projects in terms of the expected return on investment from a variety of competing projects. Alternatively, trialists can use the principles to identify the efficient sample size of a proposed study as an alternative to traditional power calculations, and finally, a value of information analysis can be conducted alongside an economic evaluation as a quantitative adjunct to the 'future research' or 'next steps' section of a study write up. The purpose of this paper is to present a brief introduction to the methods, a step-by-step guide to calculation and a discussion of issues that arise in their application to healthcare decision making. Worked examples are provided in the accompanying online appendices as Microsoft Excel spreadsheets.

Mesh:

Year:  2015        PMID: 25336432     DOI: 10.1007/s40273-014-0219-x

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  24 in total

1.  The value of information and optimal clinical trial design.

Authors:  Andrew R Willan; Eleanor M Pinto
Journal:  Stat Med       Date:  2005-06-30       Impact factor: 2.373

2.  The cost-effectiveness of testing for hepatitis C in former injecting drug users.

Authors:  E Castelnuovo; J Thompson-Coon; M Pitt; M Cramp; U Siebert; A Price; K Stein
Journal:  Health Technol Assess       Date:  2006-09       Impact factor: 4.014

3.  Cost-utility and value-of-information analysis of early versus delayed laparoscopic cholecystectomy for acute cholecystitis.

Authors:  E Wilson; K Gurusamy; C Gluud; B R Davidson
Journal:  Br J Surg       Date:  2010-02       Impact factor: 6.939

4.  The option value of delay in health technology assessment.

Authors:  Simon Eckermann; Andrew R Willan
Journal:  Med Decis Making       Date:  2008-05-13       Impact factor: 2.583

Review 5.  A systematic and critical review of the evolving methods and applications of value of information in academia and practice.

Authors:  Lotte Steuten; Gijs van de Wetering; Karin Groothuis-Oudshoorn; Valesca Retèl
Journal:  Pharmacoeconomics       Date:  2013-01       Impact factor: 4.981

6.  Decision-analytic determination of study size. The case of electronic fetal monitoring.

Authors:  M S Thompson
Journal:  Med Decis Making       Date:  1981       Impact factor: 2.583

7.  Addressing adoption and research design decisions simultaneously: the role of value of sample information analysis.

Authors:  Claire McKenna; Karl Claxton
Journal:  Med Decis Making       Date:  2011-03-10       Impact factor: 2.583

8.  Expected value of sample information calculations in medical decision modeling.

Authors:  A E Ades; G Lu; K Claxton
Journal:  Med Decis Making       Date:  2004 Mar-Apr       Impact factor: 2.583

9.  Whither trial-based economic evaluation for health care decision making?

Authors:  Mark J Sculpher; Karl Claxton; Mike Drummond; Chris McCabe
Journal:  Health Econ       Date:  2006-07       Impact factor: 3.046

10.  Comprehensive decision-analytic model and Bayesian value-of-information analysis: pentoxifylline in the treatment of chronic venous leg ulcers.

Authors:  Cynthia P Iglesias; Karl Claxton
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

View more
  37 in total

1.  Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis.

Authors:  Eric Jutkowitz; Fernando Alarid-Escudero; Hyon K Choi; Karen M Kuntz; Hawre Jalal
Journal:  Pharmacoeconomics       Date:  2017-10       Impact factor: 4.981

2.  Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis.

Authors:  Gordon Cs Smith; Alexandros A Moraitis; David Wastlund; Jim G Thornton; Aris Papageorghiou; Julia Sanders; Alexander Ep Heazell; Stephen C Robson; Ulla Sovio; Peter Brocklehurst; Edward Cf Wilson
Journal:  Health Technol Assess       Date:  2021-02       Impact factor: 4.014

3.  The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis.

Authors:  Eric Jutkowitz; Fernando Alarid-Escudero; Karen M Kuntz; Hawre Jalal
Journal:  Pharmacoeconomics       Date:  2019-07       Impact factor: 4.981

4.  Methodological Note: Reporting Deterministic versus Probabilistic Results of Markov, Partitioned Survival and Other Non-Linear Models.

Authors:  Edward C F Wilson
Journal:  Appl Health Econ Health Policy       Date:  2021-07-14       Impact factor: 2.561

5.  Cost-Effectiveness of Treatments for the Management of Bone Metastases: A Systematic Literature Review.

Authors:  Lazaros Andronis; Ilias Goranitis; Sue Bayliss; Rui Duarte
Journal:  Pharmacoeconomics       Date:  2018-03       Impact factor: 4.981

6.  Sacral nerve stimulation versus the magnetic sphincter augmentation device for adult faecal incontinence: the SaFaRI RCT.

Authors:  David G Jayne; Annabelle E Williams; Neil Corrigan; Julie Croft; Alison Pullan; Vicky Napp; Rachel Kelly; David Meads; Armando Vargas-Palacios; Adam Martin; Claire Hulme; Steven R Brown; Karen Nugent; Jen Lodge; David Protheroe; Sushil Maslekar; Andrew Clarke; Pasha Nisar; Julia M Brown
Journal:  Health Technol Assess       Date:  2021-03       Impact factor: 4.014

7.  Towards Multidisciplinary HIV-Cure Research: Integrating Social Science with Biomedical Research.

Authors:  Cynthia I Grossman; Anna Laura Ross; Judith D Auerbach; Jintanat Ananworanich; Karine Dubé; Joseph D Tucker; Veronica Noseda; Cristina Possas; Dianne M Rausch
Journal:  Trends Microbiol       Date:  2015-11-28       Impact factor: 17.079

8.  Cost-effectiveness of teduglutide in adult patients with short bowel syndrome: Markov modeling using traditional cost-effectiveness criteria.

Authors:  Vikram K Raghu; David G Binion; Kenneth J Smith
Journal:  Am J Clin Nutr       Date:  2020-01-01       Impact factor: 7.045

9.  Cost-Utility Analysis of Prophylactic Dextrose Gel vs Standard Care for Neonatal Hypoglycemia in At-Risk Infants.

Authors:  Matthew J Glasgow; Richard Edlin; Jane E Harding
Journal:  J Pediatr       Date:  2020-07-04       Impact factor: 4.406

10.  Pitfalls in Tick and Tick-Borne Pathogens Research, Some Recommendations and a Call for Data Sharing.

Authors:  Agustín Estrada-Peña; Aitor Cevidanes; Hein Sprong; Javier Millán
Journal:  Pathogens       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.